资深策略师解析：AI与信贷泡沫或已破裂，投资策略当如何调整——商业内幕
How one veteran strategist says to invest as bubbles in AI and credit may already be bursting - Business Insider
#Business Insider#veteran strategist#bursting Business#Business#Insider
生命科学资讯
生物技术与制药领域的最新动态
C. Light公司项目入选罗氏多发性硬化创新挑战赛五大精选项目——雅虎财经报道
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
#Light Named#Selected Projects#Innovation Challenge#Yahoo Finance#Challenge Yahoo
Sapphiros与罗氏达成战略合作，为罗氏提供10亿次侧流检测及未来分子即时检测服务 - 雅虎财经
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
#providing Roche#Yahoo Finance#Roche access#billion lateral#future molecular
KaliVir Immunotherapeutics宣布与罗氏达成临床试验合作与供应协议，共同评估VET3-TGI联合阿特珠单抗（Tecentriq®）治疗晚期实体瘤的效果——雅虎财经报道
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
#Immunotherapeutics Announces#Announces Clinical#Clinical Trial#Trial Collaboration#Supply Agreement
奥莱玛制药(OLMA)在罗氏乳腺癌试验成功后重新审视竞争优势 - 雅虎财经
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
#Rethinks Competitive#Competitive Edge#Breast Cancer#Cancer Trial#Olema Pharmaceuticals
罗氏：乳腺癌候选药物Giredestrant数据支持其潜在差异化地位——晨星加拿大
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
#Breast Cancer#Cancer Drug#Drug Candidate#Candidate Giredestrant#Giredestrant Support
Freenome与罗氏合作，为非美国市场开发癌症筛查技术 - 医疗器械网络
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
#Medical Device#Device Network#Roche partner#cancer screening#screening technology
欧盟委员会批准罗氏Lunsumio皮下注射剂用于复发或难治性滤泡性淋巴瘤——雅虎财经
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
#Yahoo Finance#European Commission#Commission approves#approves Roche#Lunsumio subcutaneous
罗氏癌症研究获积极成果，其竞争对手股价飙升130%——投资者商业日报
Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
#Cancer Study#Rival Flew#Investor Business#Positive Cancer#Business Daily
罗氏药丸在早期乳腺癌治疗中取得进展——生物制药动态
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
罗氏口服SERD在乳腺癌关键试验中再获成功——FirstWord Pharma
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
#oral SERD#SERD notches#Roche oral#FirstWord Pharma#pivotal breast
罗氏癌症药物试验结果积极，OLMA股价翻倍——Stocktwits报道
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
#Stock Doubles#Roche Cancer#Cancer Drug#Drug Trial#Trial Yields
罗氏口服SERD药物二期临床试验再传捷报，三期辅助乳腺癌试验达标——Fierce Biotech报道
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
#Fierce Biotech#oral SERD#hitting goal#adjuvant breast#Roche oral
Freenome与罗氏达成独家协议，扩大技术合作并在美国以外地区开发和商业化癌症筛查检测 - PR Newswire
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire
#Announces Exclusive#Exclusive Agreement#Expand Technology#Technology Collaboration#Commercialize Cancer
罗氏早期giredestrant成果获赞 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#giredestrant success#Roche touts#touts early
罗氏因乳腺癌疗法后期试验成功而提振Olema股价——Seeking Alpha报道
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha
#Seeking Alpha#boosts Olema#Roche boosts#breast cancer#cancer therapy
新型实验性药物或将改变癌症患者护理方式——独立报
New experimental drug could transform care for cancer patients - The Independent
#experimental drug#transform care#cancer patients#Independent#experimental
罗氏乳腺癌药物试验结果积极，股价应声上涨——《华尔街日报》
Roche Shares Rise After Breast-Cancer Pill Shows Positive Results in Trial - The Wall Street Journal
#Shares Rise#Pill Shows#Shows Positive#Positive Results#Wall Street
罗氏制药管线进展与股价飙升17%后，是否该重新评估其投资时机？ - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
#Stock Jump#Reassess Roche#Drug Pipeline#Pipeline Developments#Stock
罗氏公布giredestrant治疗乳腺癌的III期临床试验积极数据——临床试验竞技场
Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena
#Phase III#Clinical Trials#Trials Arena#positive Phase#III data